1	COPENHAGEN	copenhagen	NNP	p2=NN	34	nsubj	34:A0=PAG
2	,	,	,	_	1	punct	_
3	Denmark	denmark	NNP	_	1	conj	_
4	,	,	,	_	3	punct	_
5	May	may	NNP	_	3	conj	_
6	19	0	CD	_	5	num	_
7	,	,	,	_	5	punct	_
8	2014	0	CD	_	5	num	_
9	(	(	-LRB-	_	11	punct	_
10	BUSINESS	business	NNP	p2=NN	11	nn	_
11	WIRE	wire	NNP	_	1	appos	_
12	)	)	-RRB-	_	11	punct	_
13	--	--	:	_	11	punct	_
14	Symphogen	symphogen	NNP	p2=VBN	15	nn	_
15	A	a	NNP	p2=DT	17	nn	_
16	/	/	SYM	p2=,	17	punct	_
17	S	s	NNP	p2=NN	11	appos	_
18	,	,	,	_	11	punct	_
19	a	a	DT	_	22	det	_
20	private	private	JJ	_	22	amod	_
21	biopharmaceutical	biopharmaceutical	JJ	p2=NN	22	amod	_
22	company	company	NN	_	11	appos	_
23	with	with	IN	_	22	prep	_
24	leadership	leadership	NN	_	23	pobj	_
25	in	in	IN	_	24	prep	_
26	recombinant	recombinant	JJ	p2=NN	28	amod	_
27	antibody	antibody	NN	_	28	nn	_
28	mixtures	mixture	NNS	_	25	pobj	_
29	for	for	IN	_	22	prep	_
30	therapeutic	therapeutic	JJ	_	31	amod	_
31	use	use	NN	_	29	pobj	_
32	,	,	,	_	34	punct	_
33	today	today	NN	_	34	npadvmod	34:AM-TMP
34	announced	announce	VBD	pb=announce.01	0	root	_
35	the	the	DT	_	36	det	_
36	relocation	relocation	NN	_	34	dobj	34:A1=PPT
37	of	of	IN	_	36	prep	_
38	its	its	PRP$	_	40	poss	_
39	corporate	corporate	JJ	_	40	amod	_
40	headquarters	headquarters	NN	p2=NNS	37	pobj	_
41	in	in	IN	_	40	prep	_
42	Lyngby	lyngby	NNP	_	41	pobj	_
43	,	,	,	_	36	punct	_
44	outside	outside	IN	p2=JJ	36	prep	_
45	Copenhagen	copenhagen	NNP	_	44	pobj	_
46	,	,	,	_	45	punct	_
47	Denmark	denmark	NNP	_	45	appos	_
48	,	,	,	_	36	punct	_
49	to	to	IN	_	36	prep	_
50	a	a	DT	_	57	det	_
51	10,000	0	CD	_	52	num	_
52	m2	m0	NNS	p2=NN	57	nn	_
53	(	(	-LRB-	_	52	punct	_
54	100,000	0	CD	_	55	num	_
55	ft2	ft0	NN	p2=NNS	52	appos	_
56	)	)	-RRB-	_	52	punct	_
57	facility	facility	NN	_	49	pobj	_
58	in	in	IN	_	57	prep	_
59	Ballerup	ballerup	NNP	_	58	pobj	_
60	,	,	,	_	57	punct	_
61	also	also	RB	_	63	advmod	_
62	a	a	DT	_	63	det	_
63	suburb	suburb	NN	_	57	appos	_
64	of	of	IN	_	63	prep	_
65	Copenhagen	copenhagen	NNP	_	64	pobj	_
66	.	.	.	_	34	punct	_

1	Separately	separately	RB	_	4	advmod	4:AM-MNR
2	,	,	,	_	4	punct	_
3	Symphogen	symphogen	NNP	_	4	nsubj	4:A0=PAG
4	announced	announce	VBD	pb=announce.01	0	root	_
5	that	that	IN	p2=WDT	9	complm	_
6	Mads	mads	NNP	p2=NNPS	7	nn	_
7	Laustsen	laustsen	NNP	_	9	nsubjpass	9:A1=PPT
8	was	be	VBD	_	9	auxpass	_
9	appointed	appoint	VBN	pb=appoint.01	4	ccomp	4:A1=PPT
10	to	to	IN	_	9	prep	9:A2=PRD
11	the	the	DT	_	14	det	_
12	newly	newly	RB	_	13	advmod	13:AM-TMP
13	created	create	VBN	pb=create.01	14	amod	_
14	position	position	NN	_	10	pobj	13:A1=PPT
15	of	of	IN	_	14	prep	_
16	Chief	chief	NNP	_	18	nn	_
17	Manufacturing	manufacturing	NNP	_	18	nn	_
18	Officer	officer	NNP	_	15	pobj	_
19	.	.	.	_	4	punct	_

1	Mads	mads	NNS	p2=NNPS	2	nn	_
2	Laustsen	laustsen	NNP	p2=VBP	12	nsubj	12:A0=PAG
3	,	,	,	_	2	punct	_
4	one	#crd#	CD	_	2	appos	_
5	of	of	IN	_	4	prep	_
6	the	the	DT	_	7	det	_
7	founders	founder	NNS	_	5	pobj	_
8	of	of	IN	_	7	prep	_
9	CMC	cmc	NNP	_	10	nn	_
10	Biologics	biologics	NNP	p2=NNPS	8	pobj	_
11	,	,	,	_	2	punct	_
12	served	serve	VBD	pb=serve.01	0	root	_
13	as	as	IN	_	12	prep	12:A1=PPT
14	the	the	DT	_	15	det	_
15	company	company	NN	_	17	poss	_
16	's	's	POS	_	15	possessive	_
17	CEO	ceo	NN	p2=NNP	13	pobj	_
18	from	from	IN	_	12	prep	12:AM-TMP
19	the	the	DT	_	20	det	_
20	time	time	NN	_	18	pobj	_
21	of	of	IN	_	20	prep	_
22	the	the	DT	_	23	det	_
23	company	company	NN	_	25	poss	_
24	's	's	POS	_	23	possessive	_
25	inception	inception	NN	_	21	pobj	_
26	2001	0	CD	_	25	num	_
27	until	until	IN	_	18	prep	_
28	May	may	NNP	_	27	pobj	34:AM-TMP
29	2011	0	CD	_	28	num	_
30	,	,	,	_	28	punct	_
31	when	when	WRB	_	34	advmod	34:R-AM-TMP
32	he	he	PRP	_	34	nsubjpass	34:A1=PPT
33	was	be	VBD	_	34	auxpass	_
34	named	name	VBN	pb=name.01	28	rcmod	_
35	to	to	IN	_	34	prep	34:A2=PRD
36	the	the	DT	_	37	det	_
37	Board	board	NNP	_	35	pobj	_
38	of	of	IN	_	37	prep	_
39	Directors	director	NNPS	p2=NNS	38	pobj	_
40	.	.	.	_	12	punct	_

1	During	during	IN	_	7	prep	7:AM-TMP
2	this	this	DT	_	3	det	_
3	period	period	NN	_	1	pobj	_
4	,	,	,	_	7	punct	_
5	the	the	DT	_	6	det	_
6	company	company	NN	_	7	nsubj	7:A1=PPT
7	grew	grow	VBD	pb=grow.01	0	root	_
8	from	from	IN	_	7	prep	7:A3=DIR
9	a	a	DT	_	11	det	_
10	business	business	NN	_	11	nn	_
11	idea	idea	NN	_	8	pobj	_
12	to	to	IN	_	7	prep	7:A4=PRD
13	a	a	DT	_	15	det	_
14	global	global	JJ	_	15	amod	_
15	leader	leader	NN	_	12	pobj	_
16	in	in	IN	_	15	prep	_
17	contract	contract	NN	_	18	nn	_
18	biologics	biologics	NNS	p2=NN	19	nn	_
19	manufacturing	manufacturing	NN	p2=VBG	16	pobj	_
20	.	.	.	_	7	punct	_

1	Laustsen	laustsen	NNP	p2=VBN	2	nsubj	2:A0=PAG;8:A1=PPT
2	joins	join	VBZ	pb=join.01	0	root	_
3	Symphogen	symphogen	NNP	_	4	nn	_
4	June	june	NNP	_	2	dobj	2:A1=PPT
5	1	0	CD	_	4	num	_
6	,	,	,	_	2	punct	_
7	but	but	CC	_	2	cc	_
8	remains	remain	VBZ	pb=remain.01	2	conj	_
9	a	a	DT	_	11	det	_
10	non-executive	non-executive	JJ	_	11	amod	_
11	Director	director	NNP	p2=NN	8	attr	8:A3=PRD
12	on	on	IN	_	11	prep	_
13	the	the	DT	_	16	det	_
14	CMC	cmc	NNP	_	16	nn	_
15	Biologics	biologics	NNP	p2=NNPS	16	nn	_
16	Board	board	NNP	_	12	pobj	_
17	.	.	.	_	2	punct	_

1	Prior	prior	RB	_	8	advmod	8:AM-TMP
2	to	to	IN	_	1	prep	_
3	establishing	establish	VBG	pb=establish.01	2	pcomp	_
4	CMC	cmc	NNP	_	5	nn	_
5	Biologics	biologics	NNP	p2=NNPS	3	dobj	3:A1=PPT
6	,	,	,	_	8	punct	_
7	he	he	PRP	_	8	nsubj	8:A0=PAG;13:A0=PAG;11:A1=LOC
8	spent	spend	VBD	pb=spend.02	0	root	_
9	16	0	CD	_	10	num	_
10	years	year	NNS	_	8	dobj	8:A1=VSP
11	developing	develop	VBG	pb=develop.01	8	xcomp	8:A2=GOL
12	and	and	CC	_	11	cc	_
13	manufacturing	manufacture	VBG	p2=NN|pb=manufacture.01	11	conj	_
14	bulk	bulk	NN	p2=JJ	15	amod	_
15	enzymes	enzyme	NNS	p2=RB	13	dobj	13:A1=PRD
16	and	and	CC	_	15	cc	_
17	biopharmaceuticals	biopharmaceuticals	NNS	_	15	conj	_
18	at	at	IN	_	13	prep	13:AM-LOC
19	Novo	novo	NNP	_	20	nn	_
20	Nordisk	nordisk	NNP	_	18	pobj	_
21	,	,	,	_	20	punct	_
22	Zymogenetics	zymogenetics	NNP	p2=NNPS	20	appos	_
23	,	,	,	_	20	punct	_
24	and	and	CC	_	20	cc	_
25	Novozymes	novozymes	NNP	p2=NNPS	20	conj	_
26	.	.	.	_	8	punct	_

1	Laustsen	laustsen	NNP	_	3	nsubj	3:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	served	serve	VBN	pb=serve.01	13	ccomp	_
4	as	as	IN	_	3	prep	3:A1=PPT
5	a	a	DT	_	6	det	_
6	member	member	NN	_	4	pobj	_
7	of	of	IN	_	6	prep	_
8	various	various	JJ	_	10	amod	_
9	advisory	advisory	JJ	_	10	amod	_
10	boards	board	NNS	_	7	pobj	_
11	,	,	,	_	13	punct	_
12	has	have	VBZ	_	13	aux	_
13	been	be	VBN	pb=be.01	0	root	_
14	active	active	JJ	_	13	acomp	13:A2=PRD
15	in	in	IN	_	13	prep	13:AM-LOC
16	development	development	NN	_	15	pobj	_
17	of	of	IN	_	16	prep	_
18	new	new	JJ	_	20	amod	_
19	process	process	NN	_	20	nn	_
20	technologies	technology	NNS	_	17	pobj	_
21	,	,	,	_	13	punct	_
22	and	and	CC	_	13	cc	_
23	holds	hold	VBZ	pb=hold.04	13	conj	_
24	numerous	numerous	JJ	_	25	amod	_
25	patents	patent	NNS	_	23	dobj	23:A1=PPT
26	in	in	IN	_	25	prep	_
27	the	the	DT	_	28	det	_
28	field	field	NN	_	26	pobj	_
29	.	.	.	_	13	punct	_

1	Symphogen	symphogen	NNP	p2=NN	3	nsubj	3:A0=PAG;16:A1=PPT
2	is	be	VBZ	_	3	aux	_
3	developing	develop	VBG	pb=develop.02	0	root	_
4	next	next	JJ	p2=RB	6	hmod	_
5	-	-	HYPH	_	6	hyph	_
6	generation	generation	NN	_	8	nn	_
7	antibody	antibody	NN	_	8	nn	_
8	therapeutics	therapeutic	NNS	p2=NN	3	dobj	3:A1=PRD
9	for	for	IN	_	8	prep	_
10	the	the	DT	_	11	det	_
11	treatment	treatment	NN	_	9	pobj	_
12	of	of	IN	_	11	prep	_
13	cancer	cancer	NN	_	12	pobj	_
14	and	and	CC	_	3	cc	_
15	is	be	VBZ	_	16	auxpass	_
16	dedicated	dedicate	VBN	p2=JJ|pb=dedicate.01	3	conj	_
17	to	to	IN	_	16	prep	16:A2=GOL
18	bringing	bring	VBG	pb=bring.01	17	pcomp	_
19	truly	truly	RB	_	20	advmod	_
20	innovative	innovative	JJ	_	22	amod	_
21	oncology	oncology	NN	p2=IN	22	nn	_
22	products	product	NNS	_	18	dobj	18:A1=PPT
23	to	to	IN	_	18	prep	18:A2=GOL
24	the	the	DT	_	25	det	_
25	market	market	NN	_	23	pobj	_
26	.	.	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	4	nsubj	4:A0=PAG
3	has	have	VBZ	_	4	aux	_
4	advanced	advance	VBN	p2=JJ|pb=advance.01	0	root	_
5	the	the	DT	_	6	det	_
6	frontier	frontier	NN	_	4	dobj	4:A1=PPT
7	of	of	IN	_	6	prep	_
8	antibody	antibody	NN	_	9	nn	_
9	discovery	discovery	NN	_	7	pobj	_
10	by	by	IN	_	4	prep	4:AM-MNR
11	creating	create	VBG	pb=create.01	10	pcomp	_
12	well	well	RB	_	14	hmod	_
13	-	-	HYPH	_	14	hyph	_
14	characterized	characterize	VBN	_	16	amod	_
15	antibody	antibody	NN	_	16	nn	_
16	mixtures	mixture	NNS	p2=VBZ	11	dobj	18:A0=PAG;11:A1=PPT
17	that	that	WDT	_	18	nsubj	18:R-A0
18	address	address	VBP	pb=address.02	16	rcmod	_
19	multiple	multiple	JJ	_	21	amod	_
20	oncology	oncology	NN	p2=IN	21	nn	_
21	targets	target	NNS	_	18	dobj	18:A1=PPT
22	in	in	IN	_	21	prep	_
23	a	a	DT	_	26	det	_
24	single	single	JJ	_	26	amod	_
25	drug	drug	NN	_	26	nn	_
26	product	product	NN	_	22	pobj	_
27	.	.	.	_	4	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	4	nsubj	11:A0=PAG
3	has	have	VBZ	_	4	aux	_
4	matured	mature	VBN	pb=mature.01	0	root	_
5	its	its	PRP$	_	7	poss	_
6	oncology	oncology	NN	p2=JJ	7	nn	_
7	pipeline	pipeline	NN	_	4	dobj	4:A1=PPT
8	and	and	CC	_	4	cc	_
9	has	have	VBZ	_	11	aux	_
10	currently	currently	RB	_	11	advmod	11:AM-TMP
11	brought	bring	VBN	pb=bring.01	4	conj	_
12	two	#crd#	CD	_	14	num	_
13	product	product	NN	_	14	nn	_
14	candidates	candidate	NNS	p2=VBZ	11	dobj	11:A1=PPT
15	into	into	IN	_	11	prep	11:A2=GOL
16	the	the	DT	_	17	det	_
17	clinic	clinic	NN	_	15	pobj	_
18	.	.	.	_	4	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	18	poss	_
3	's	's	POS	_	2	possessive	_
4	productive	productive	JJ	_	5	amod	_
5	technology	technology	NN	_	0	root	_
6	suite	suite	NN	_	8	hmod	_
7	-	-	HYPH	p2=,	8	hyph	_
8	capable	capable	JJ	_	5	amod	_
9	of	of	IN	_	8	prep	_
10	identifying	identify	VBG	p2=NN|pb=identify.01	9	pcomp	_
11	,	,	,	_	10	punct	_
12	selecting	select	VBG	pb=select.01	10	conj	_
13	,	,	,	_	12	punct	_
14	and	and	CC	_	12	cc	_
15	manufacturing	manufacture	VBG	p2=NN|pb=manufacture.01	12	conj	_
16	optimal	optimal	JJ	p2=NN	18	amod	_
17	antibody	antibody	NN	_	18	nn	_
18	mixtures	mixture	NNS	_	15	dobj	15:A1=PRD
19	-	-	:	p2=HYPH	24	punct	_
20	fuels	fuel	NNS	_	21	nn	_
21	Symphogen	symphogen	NNP	_	24	poss	_
22	's	's	POS	_	21	possessive	_
23	innovative	innovative	JJ	_	24	amod	_
24	pipeline	pipeline	NN	_	18	appos	_
25	.	.	.	_	5	punct	_

1	The	the	DT	_	4	det	_
2	lead	lead	JJ	p2=NN	4	amod	_
3	oncology	oncology	NN	p2=JJ	4	nn	_
4	product	product	NN	_	11	nsubjpass	_
5	,	,	,	_	4	punct	_
6	Sym004	sym004	NNP	p2=NN	4	appos	_
7	,	,	,	_	4	punct	_
8	was	be	VBD	_	11	auxpass	_
9	out	out	RB	p2=JJ	11	advmod	_
10	-	-	HYPH	p2=:	11	hyph	_
11	licensed	license	VBN	p2=JJ	0	root	_
12	to	to	IN	_	11	prep	_
13	Merck	merck	NNP	_	14	nn	_
14	KGaA	kgaa	NNP	_	12	pobj	_
15	in	in	IN	_	11	prep	_
16	2012	0	CD	_	15	pobj	_
17	following	follow	VBG	_	11	prep	_
18	phase	phase	NN	_	21	nn	_
19	2	0	CD	_	18	num	_
20	clinical	clinical	JJ	_	21	amod	_
21	data	datum	NNS	_	17	pobj	_
22	in	in	IN	_	21	prep	_
23	late	late	JJ	_	24	amod	_
24	stage	stage	NN	_	25	nn	_
25	cancer	cancer	NN	_	26	nn	_
26	patients	patient	NNS	_	22	pobj	_
27	.	.	.	_	11	punct	_

1	In	in	IN	_	7	prep	7:AM-LOC
2	total	total	NN	p2=JJ	1	pobj	_
3	,	,	,	_	7	punct	_
4	the	the	DT	_	5	det	_
5	company	company	NN	_	7	nsubj	7:A0=PAG
6	has	have	VBZ	_	7	aux	_
7	raised	raise	VBN	pb=raise.01	0	root	_
8	€249	€0	CD	p2=,	9	number	_
9	million	#crd#	CD	_	7	dobj	7:A1=PPT
10	in	in	IN	_	9	prep	_
11	equity	equity	NN	_	12	nn	_
12	capital	capital	NN	_	10	pobj	_
13	from	from	IN	_	7	prep	7:A3=DIR
14	premier	premier	NN	p2=JJ	16	amod	_
15	international	international	JJ	_	16	amod	_
16	investors	investor	NNS	_	13	pobj	_
17	including	include	VBG	_	16	prep	_
18	Novo	novo	NNP	_	17	pobj	_
19	,	,	,	_	18	punct	_
20	Essex	essex	NNP	_	23	nn	_
21	Woodlands	woodlands	NNP	p2=VBZ	23	nn	_
22	Health	health	NNP	_	23	nn	_
23	Ventures	venture	NNPS	p2=NNP	18	conj	_
24	,	,	,	_	23	punct	_
25	and	and	CC	_	23	cc	_
26	PKA	pka	NNP	_	23	conj	_
27	,	,	,	_	23	punct	_
28	and	and	CC	_	23	cc	_
29	employs	employ	VBZ	pb=employ.01	23	conj	_
30	100	0	CD	_	31	num	_
31	people	people	NNS	_	29	dobj	29:A1=PPT
32	,	,	,	_	31	punct	_
33	most	most	JJS	_	37	nsubjpass	37:A1=PPT
34	of	of	IN	_	33	prep	_
35	whom	whom	WP	_	34	pobj	_
36	are	be	VBP	_	37	auxpass	_
37	based	base	VBN	pb=base.02	31	rcmod	_
38	at	at	IN	_	37	prep	37:AM-LOC
39	Symphogen	symphogen	NNP	_	41	poss	_
40	's	's	POS	_	39	possessive	_
41	facilities	facility	NNS	_	38	pobj	_
42	in	in	IN	_	41	prep	_
43	Copenhagen	copenhagen	NNP	_	42	pobj	_
44	.	.	.	_	7	punct	_

1	Copyright	copyright	NN	_	0	root	_
2	©2014	©0	CD	p2=NN	1	punct	_
3	MarketWatch	marketwatch	NNP	p2=NN	1	npadvmod	_
4	,	,	,	_	3	punct	_
5	Inc	inc	NNP	_	3	appos	_
6	.	.	.	_	1	punct	_

1	All	all	DT	_	2	det	_
2	rights	right	NNS	_	3	nsubj	3:A1=PPT
3	reserved	reserve	VBN	p2=VBD|pb=reserve.01	0	root	_
4	.	.	.	_	3	punct	_

1	Intraday	intraday	NNP	_	2	nn	_
2	Data	data	NNP	p2=NN	3	nsubj	3:A1
3	provided	provided	VBN	pb=provide.01	0	root	_
4	by	by	IN	_	3	agent	3:A0
5	SIX	six	NNP	_	7	nn	_
6	Financial	financial	NNP	_	7	nn	_
7	Information	information	NNP	p2=NN	4	pobj	_
8	and	and	CC	_	7	cc	_
9	subject	subject	JJ	p2=VB	7	conj	_
10	to	to	IN	_	9	prep	_
11	terms	term	NNS	_	10	pobj	_
12	of	of	IN	_	11	prep	_
13	use	use	NN	_	12	pobj	_
14	.	.	.	_	3	punct	_

1	Historical	historical	JJ	p2=NNP	9	amod	_
2	and	and	CC	_	1	cc	_
3	current	current	JJ	_	9	amod	_
4	end	end	NN	p2=JJ	8	hmod	_
5	-	-	HYPH	_	8	hyph	_
6	of	of	IN	_	8	hmod	_
7	-	-	HYPH	_	8	hyph	_
8	day	day	NN	_	9	nn	_
9	data	datum	NNS	_	0	root	10:A1
10	provided	provided	VBN	pb=provide.01	9	partmod	_
11	by	by	IN	_	10	agent	10:A0
12	SIX	six	NNP	_	14	nn	_
13	Financial	financial	NNP	p2=JJ	14	nn	_
14	Information	information	NNP	p2=NN	11	pobj	_
15	.	.	.	_	9	punct	_

1	Intraday	intraday	JJ	p2=NNP	2	amod	_
2	data	datum	NNS	p2=NN	0	root	3:A1=PPT
3	delayed	delay	VBN	pb=delay.01	2	partmod	_
4	per	per	IN	_	3	prep	3:A2=TMP
5	exchange	exchange	NN	_	6	nn	_
6	requirements	requirement	NNS	_	4	pobj	_
7	.	.	.	_	2	punct	_

1	S&P	s&p	NNP	_	0	root	_
2	/	/	SYM	_	1	punct	_
3	Dow	dow	NNP	_	4	nn	_
4	Jones	jones	NNP	_	7	nn	_
5	Indices	indices	NNP	p2=NNPS	7	nn	_
6	(	(	-LRB-	_	7	punct	_
7	SM	sm	NNP	_	1	appos	_
8	)	)	-RRB-	_	1	punct	_
9	from	from	IN	_	1	prep	_
10	Dow	dow	NNP	_	11	nn	_
11	Jones	jones	NNP	_	15	nn	_
12	&	&	CC	_	11	cc	_
13	Company	company	NNP	_	11	conj	_
14	,	,	,	_	15	punct	_
15	Inc	inc	NNP	_	9	pobj	_
16	.	.	.	_	1	punct	_

1	All	all	DT	p2=PDT	2	det	_
2	quotes	quote	NNS	_	3	nsubj	3:A1=PPT
3	are	be	VBP	pb=be.01	0	root	_
4	in	in	IN	_	3	prep	3:A2=PRD
5	local	local	JJ	_	7	amod	_
6	exchange	exchange	NN	_	7	nn	_
7	time	time	NN	_	4	pobj	_
8	.	.	.	_	3	punct	_

1	Real	real	JJ	_	2	amod	_
2	time	time	NN	_	5	nn	_
3	last	last	JJ	_	5	amod	_
4	sale	sale	NN	_	5	nn	_
5	data	datum	NNS	p2=NN	0	root	6:A1
6	provided	provided	VBN	pb=provide.01	5	partmod	_
7	by	by	IN	_	6	agent	6:A0
8	NASDAQ	nasdaq	NNP	_	7	pobj	_
9	.	.	.	_	2	punct	_

1	More	more	JJR	_	2	amod	_
2	information	information	NN	_	5	nsubj	5:A0=PAG
3	on	on	IN	_	2	prep	_
4	NASDAQ	nasdaq	NNP	_	3	pobj	_
5	traded	trade	VBD	p2=VBN|pb=trade.01	0	root	_
6	symbols	symbol	NNS	_	5	dobj	5:A1=PPT
7	and	and	CC	_	6	cc	_
8	their	their	PRP$	_	11	poss	_
9	current	current	JJ	_	11	amod	_
10	financial	financial	JJ	_	11	amod	_
11	status	status	NN	_	6	conj	_
12	.	.	.	_	5	punct	_

1	Intraday	intraday	NNP	p2=JJ	2	nn	_
2	data	datum	NNS	p2=NN	3	nsubj	3:A0=PAG
3	delayed	delay	VBD	pb=delay.01	0	root	_
4	15	0	CD	_	5	num	_
5	minutes	minute	NNS	_	3	dobj	3:A1=PPT
6	for	for	IN	_	5	prep	_
7	Nasdaq	nasdaq	NNP	_	6	pobj	_
8	,	,	,	_	3	punct	_
9	and	and	CC	_	3	cc	_
10	20	0	CD	_	11	num	_
11	minutes	minute	NNS	_	3	conj	_
12	for	for	IN	_	11	prep	_
13	other	other	JJ	_	14	amod	_
14	exchanges	exchange	NNS	_	12	pobj	_
15	.	.	.	_	3	punct	_

1	S&P	s&p	NNP	_	0	root	_
2	/	/	SYM	_	1	punct	_
3	Dow	dow	NNP	_	4	nn	_
4	Jones	jones	NNP	_	7	nn	_
5	Indices	indices	NNP	p2=NNPS	7	nn	_
6	(	(	-LRB-	_	7	punct	_
7	SM	sm	NNP	_	1	appos	_
8	)	)	-RRB-	_	1	punct	_
9	from	from	IN	_	1	prep	_
10	Dow	dow	NNP	_	11	nn	_
11	Jones	jones	NNP	_	15	nn	_
12	&	&	CC	_	11	cc	_
13	Company	company	NNP	_	11	conj	_
14	,	,	,	_	15	punct	_
15	Inc	inc	NNP	_	9	pobj	_
16	.	.	.	_	1	punct	_

1	SEHK	sehk	NN	p2=NNP	3	nn	_
2	intraday	intraday	NN	_	3	nn	_
3	data	datum	NNS	p2=NN	5	nsubjpass	5:A1;11:A1=PPT
4	is	be	VBZ	_	5	auxpass	_
5	provided	provided	VBN	pb=provide.01	0	root	_
6	by	by	IN	_	5	agent	5:A0
7	SIX	six	NNP	_	9	nn	_
8	Financial	financial	NNP	_	9	nn	_
9	Information	information	NNP	p2=NN	6	pobj	_
10	and	and	CC	_	5	cc	_
11	is	be	VBZ	pb=be.01	5	conj	_
12	at	at	IN	_	13	advmod	_
13	least	least	JJS	_	14	advmod	_
14	60	0	CD	_	16	hmod	_
15	-	-	HYPH	_	16	hyph	_
16	minutes	minute	NNS	_	17	npadvmod	17:A1=PPT
17	delayed	delay	VBN	p2=VBD|pb=delay.01	11	acomp	11:A2=PRD
18	.	.	.	_	5	punct	_

1	All	all	DT	p2=PDT	2	det	_
2	quotes	quote	NNS	_	3	nsubj	3:A1=PPT
3	are	be	VBP	pb=be.01	0	root	_
4	in	in	IN	_	3	prep	3:A2=PRD
5	local	local	JJ	_	7	amod	_
6	exchange	exchange	NN	_	7	nn	_
7	time	time	NN	_	4	pobj	_
8	.	.	.	_	3	punct	_

